Aditya Birla Sun Life Pharma and Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Chart Comparison
Overview
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8114 Cr | ₹830 Cr |
| Min Investment | ₹5000 | ₹1000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 10 Jul 2019 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 31% |
| Expense Ratio | 1.82 | 2.27 |
| Manager | Sailesh Raj Bhan | Dhaval Joshi |
| ISIN Code | INF204K01968 | INF209KB1N91 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 1 Month | 2.16% | 1.21% |
| 6 Month | 3.03% | 3.33% |
| 1 Year | -0.53% | -1.43% |
| 3 Year | 20.87% | 20.63% |
| 5 Year | 18.19% | 16.17% |
SIP Return Analysis
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 6 Month | -0.19% | 0.89% |
| 1 Year | 5.08% | 5.74% |
| 3 Year | 18.94% | 18.92% |
| 5 Year | 17.4% | 16.61% |
Rolling Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 1 Year | 16.99% | 23.67% |
| 3 Year | 20.8% | 17.01% |
| 5 Year | 20.54% | 21.83% |
Risk Management
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Standard Deviation | 15.22% | 16.01% |
| Sharp | 0.89% | 0.85% |
| Beta | 0.91% | 0.96% |
| Alpha | -0.46% | -1.08% |
Fund Managers
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Dhaval Joshi |
| Total AUM | ₹96086 Cr | ₹361932 Cr |
| Funds Managed | 5 | 55 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Market Cap
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Others | 1.52 | 4.88 |
| Large Cap | 33.27 | 25.69 |
| Mid Cap | 33.86 | 41.06 |
| Small Cap | 31.35 | 28.36 |
Sector Allocation
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Others | 0.53 | 1.66 |
| Healthcare | 99.47 | 97.35 |
| Basic Materials | - | 0.99 |
Top Comparisons
ICICI Prudential Medium Term Bond Fund - Growth
3Y Returns8.05%
HDFC Medium Term Debt Fund - Growth Option
3Y Returns7.64%
Franklin India Aggressive Hybrid Fund - Growth Plan
3Y Returns14.54%
Nippon India Aggressive Hybrid Fund - Regular - Growth
3Y Returns15.29%
Kotak Focused Fund- Regular plan _ Growth Option
3Y Returns16.01%
HSBC Focused Fund - Regular Growth
3Y Returns16.1%
HSBC Banking and PSU Debt Fund - Regular Growth
3Y Returns7.33%
Axis Banking & PSU Debt Fund - Regular Plan - Growth option
3Y Returns7.36%